Literature DB >> 30159755

Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells.

Susan Richter1, Vanessa D'Antongiovanni2, Serena Martinelli2, Nicole Bechmann1, Maria Riverso2, David M Poitz1, Karel Pacak3, Graeme Eisenhofer1, Massimo Mannelli2, Elena Rapizzi4.   

Abstract

Pheochromocytomas and paragangliomas (PGLs) due to mutations of succinate dehydrogenase (SDH) B, a subunit of the SDH complex with a role in the Krebs cycle and the respiratory chain, tend to be larger at diagnosis and more prone to metastatic disease than other tumors. This presentation contrasts with the behavior of some cell line models of SDHB impairment, which show reduced growth compared to wild type. We hypothesize that reduced growth of SDHB-impaired monolayer culture models might reflect lack of support from sources within the tumor microenvironment. The present study therefore investigates how the microenvironment, modeled here by fibroblast co-culture, modulates cell metabolism, growth and invasion in an Sdhb-impaired mouse pheochromocytoma cell line. We employed two different constructs of short hairpin RNA to knockdown Sdhb and compared growth in a monolayer with and without fibroblast co-culture. Sdhb-silenced cells showed functional impairment of SDH with elevated succinate to fumarate ratio and decreased oxidative capacity. Cell growth was delayed with an increase in doubling time of 2 h or 20 h. Clonogenic cell survival and viability, on the other hand, were either unchanged or increased compared to control. In standard monolayer culture, no differences in pro-metastatic features were present. Co-culture with primary mouse fibroblast reversed the difference of proliferation between control and Sdhb knockdown but was unable to significantly influence invasiveness under these culture conditions. Metabolic studies identified that lactate secreted by fibroblasts was taken up preferentially by Sdhb-silenced cells. In summary, the present study identified a potential role for the tumor microenvironment in influencing phenotypic features of SDHB-mutated PGLs, providing a basis for the use of therapies targeted towards the tumor microenvironment.

Entities:  

Keywords:  Lactate; Paraganglioma; Pheochromocytoma; Succinate dehydrogenase; Tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 30159755      PMCID: PMC7350657          DOI: 10.1007/s00441-018-2907-x

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  30 in total

Review 1.  Accessories to the crime: functions of cells recruited to the tumor microenvironment.

Authors:  Douglas Hanahan; Lisa M Coussens
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

2.  Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.

Authors:  Ionica Masgras; Francesco Ciscato; Anna Maria Brunati; Elena Tibaldi; Stefano Indraccolo; Matteo Curtarello; Federica Chiara; Giuseppe Cannino; Elena Papaleo; Matteo Lambrughi; Giulia Guzzo; Alberto Gambalunga; Marco Pizzi; Vincenza Guzzardo; Massimo Rugge; Stefania Edith Vuljan; Fiorella Calabrese; Paolo Bernardi; Andrea Rasola
Journal:  Cell Rep       Date:  2017-01-17       Impact factor: 9.423

3.  The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids.

Authors:  Vanessa D'Antongiovanni; Serena Martinelli; Susan Richter; Letizia Canu; Daniele Guasti; Tommaso Mello; Paolo Romagnoli; Karel Pacak; Graeme Eisenhofer; Massimo Mannelli; Elena Rapizzi
Journal:  Endocr Relat Cancer       Date:  2017-10       Impact factor: 5.678

4.  Loss of SDHB Elevates Catecholamine Synthesis and Secretion Depending on ROS Production and HIF Stabilization.

Authors:  Yuria Saito; Kiyo-Aki Ishii; Yuichi Aita; Tatsuhiko Ikeda; Yasushi Kawakami; Hitoshi Shimano; Hisato Hara; Kazuhiro Takekoshi
Journal:  Neurochem Res       Date:  2015-11-30       Impact factor: 3.996

5.  Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations.

Authors:  Kathryn S King; Tamara Prodanov; Vitaly Kantorovich; Tito Fojo; Jacqueline K Hewitt; Margaret Zacharin; Robert Wesley; Maya Lodish; Margarita Raygada; Anne-Paule Gimenez-Roqueplo; Shana McCormack; Graeme Eisenhofer; Dragana Milosevic; Electron Kebebew; Constantine A Stratakis; Karel Pacak
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

6.  Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.

Authors:  Susan Richter; Mirko Peitzsch; Elena Rapizzi; Jacques W Lenders; Nan Qin; Aguirre A de Cubas; Francesca Schiavi; Jyotsna U Rao; Felix Beuschlein; Marcus Quinkler; Henri J Timmers; Giuseppe Opocher; Massimo Mannelli; Karel Pacak; Mercedes Robledo; Graeme Eisenhofer
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

7.  Cells silenced for SDHB expression display characteristic features of the tumor phenotype.

Authors:  Ana M Cervera; Nadezda Apostolova; Francisco Luna Crespo; Manuel Mata; Kenneth J McCreath
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

8.  Morphology, Biochemistry, and Pathophysiology of MENX-Related Pheochromocytoma Recapitulate the Clinical Features.

Authors:  Tobias Wiedemann; Mirko Peitzsch; Nan Qin; Frauke Neff; Monika Ehrhart-Bornstein; Graeme Eisenhofer; Natalia S Pellegata
Journal:  Endocrinology       Date:  2016-06-02       Impact factor: 4.736

9.  Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas.

Authors:  Christina Pamporaki; Barbora Hamplova; Mirko Peitzsch; Aleksander Prejbisz; Felix Beuschlein; Henri J L M Timmers; Martin Fassnacht; Barbara Klink; Maya Lodish; Constantine A Stratakis; Angela Huebner; Stephanie Fliedner; Mercedes Robledo; Richard O Sinnott; Andrzej Januszewicz; Karel Pacak; Graeme Eisenhofer
Journal:  J Clin Endocrinol Metab       Date:  2017-04-01       Impact factor: 5.958

10.  Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis.

Authors:  Simone Cardaci; Liang Zheng; Gillian MacKay; Niels J F van den Broek; Elaine D MacKenzie; Colin Nixon; David Stevenson; Sergey Tumanov; Vinay Bulusu; Jurre J Kamphorst; Alexei Vazquez; Stewart Fleming; Francesca Schiavi; Gabriela Kalna; Karen Blyth; Douglas Strathdee; Eyal Gottlieb
Journal:  Nat Cell Biol       Date:  2015-08-24       Impact factor: 28.824

View more
  8 in total

1.  Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity.

Authors:  Vanessa D'Antongiovanni; Laura Benvenuti; Matteo Fornai; Carolina Pellegrini; Renè van den Wijngaard; Silvia Cerantola; Maria Cecilia Giron; Valentina Caputi; Rocchina Colucci; Gyorgy Haskó; Zoltán H Németh; Corrado Blandizzi; Luca Antonioli
Journal:  Cells       Date:  2020-05-18       Impact factor: 6.600

Review 2.  The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia.

Authors:  Vanessa D'Antongiovanni; Matteo Fornai; Carolina Pellegrini; Laura Benvenuti; Corrado Blandizzi; Luca Antonioli
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

3.  Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition.

Authors:  Carolina Pellegrini; Simona Daniele; Luca Antonioli; Laura Benvenuti; Vanessa D'Antongiovanni; Rebecca Piccarducci; Deborah Pietrobono; Valentina Citi; Eugenia Piragine; Lorenzo Flori; Chiara Ippolito; Cristina Segnani; Pablo Palazon-Riquelme; Gloria Lopez-Castejon; Alma Martelli; Rocchina Colucci; Nunzia Bernardini; Maria Letizia Trincavelli; Vincenzo Calderone; Claudia Martini; Corrado Blandizzi; Matteo Fornai
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

4.  Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas.

Authors:  Dieter M Matlac; Katerina Hadrava Vanova; Nicole Bechmann; Susan Richter; Julica Folberth; Hans K Ghayee; Guang-Bo Ge; Luma Abunimer; Robert Wesley; Redouane Aherrahrou; Margo Dona; Ángel M Martínez-Montes; Bruna Calsina; Maria J Merino; Markus Schwaninger; Peter M T Deen; Zhengping Zhuang; Jiri Neuzil; Karel Pacak; Hendrik Lehnert; Stephanie M J Fliedner
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

5.  Treatment of Pheochromocytoma Cells with Recurrent Cycles of Hypoxia: A New Pseudohypoxic In Vitro Model.

Authors:  Jana Helm; Stephan Drukewitz; Isabel Poser; Susan Richter; Markus Friedemann; Doreen William; Hermine Mohr; Svenja Nölting; Mercedes Robledo; Stefan R Bornstein; Graeme Eisenhofer; Nicole Bechmann
Journal:  Cells       Date:  2022-02-05       Impact factor: 6.600

6.  Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts.

Authors:  Serena Martinelli; Francesca Amore; Tommaso Mello; Massimo Mannelli; Mario Maggi; Elena Rapizzi
Journal:  Cancers (Basel)       Date:  2022-07-17       Impact factor: 6.575

7.  Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomas.

Authors:  Jean-Pierre Bayley; Heggert G Rebel; Kimberly Scheurwater; Dominique Duesman; Juan Zhang; Francesca Schiavi; Esther Korpershoek; Jeroen C Jansen; Abbey Schepers; Peter Devilee
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

Review 8.  Model systems in SDHx-related pheochromocytoma/paraganglioma.

Authors:  Krisztina Takács-Vellai; Zsolt Farkas; Fanni Ősz; Gordon W Stewart
Journal:  Cancer Metastasis Rev       Date:  2021-12-27       Impact factor: 9.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.